Notice of Intent to Sole Source – Global Life Sciences Solutions USA 26-000302
Summary
AI-generated · Jan 14, 2026A fixed-price preventative maintenance contract is being sought for four ViaFreeze Quad units and three ViaThaw MD/L1000 devices housed in the NIH Clinical Center's Center for Cellular Engineering in Bethesda, MD. Global Life Sciences Solutions USA LLC (Cytiva) is the intended sole-source provider, as the manufacturer is the only entity capable of performing maintenance on this highly specialized equipment.
This is a notice of intent to sole source under FAR Part 13 Simplified Acquisition Procedures (Subpart 13.106-1(b)(1)); no solicitation will be issued and quotes will not be requested. The government will consider other parties that can identify their interest and capabilities in response to this posting, but the decision not to compete rests with the government. Comments referencing this posting number may be submitted to the NIH Clinical Center, Office of Purchasing and Contracts, attention Kristin Nagashima, prior to the posting’s closing date.
The purpose of this acquisition is to procure a preventative maintenance contract for four (4) ViaFreeze Quad and three (3) ViaThaw MD/L1000 devices located in the Center for Cellular Engineering at the Clinical Center (CC) of the National Institutes of Health (NIH), Bethesda, MD. Product Service Code: 6515 Medical Instruments, Equipment, and Supplies NAICS Code: 339112 Surgical and Medical Instrument Manufacturing Place of Performance: Bethesda, MD 20892 USA POTS: 26-000302 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Global Life Sciences Solutions USA, located at 100 Results Way, Marlborough, MA, on a firm fixed price sole source award basis to provide preventative maintenance to the National Institutes of Health Center for Cellular Engineering. Only one source is available: Cytiva/Global Life Sciences Solutions USA LLC. The manufacturer is the sole source for preventative maintenance of this highly specialized equipment. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by January 20, 2025 at 12pm EST.
From Special Notice posted on Jan 13, 2026Notice history
1-
Special Notice LATEST Posted Jan 13, 2026
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA